Related Experiment Videos
Statin therapy in rheumatoid arthritis
Karen H Costenbader1, Jonathan S Coblyn
1Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. kcostenbader@partners.org
Southern Medical Journal
|June 16, 2005
Summary
Statins may offer anti-inflammatory benefits for rheumatoid arthritis (RA) patients, beyond their cholesterol-lowing effects. These drugs also reduce cardiovascular risk in RA, a condition linked to inflammation and heart disease.
Area of Science:
- Rheumatology
- Cardiology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting joints, increasing cardiovascular disease (CVD) risk.
- CVD risk in RA patients is not fully explained by traditional factors.
- Statins, HMG-CoA reductase inhibitors, effectively reduce cardiovascular mortality.
Purpose of the Study:
- To investigate the potential anti-inflammatory effects of statins in rheumatoid arthritis.
- To explore the role of statins in mitigating cardiovascular risk associated with RA.
Main Methods:
- Review of recent studies on statin use in rheumatoid arthritis patients.
- Analysis of statin's impact on inflammatory pathways relevant to RA.
- Evaluation of cardiovascular outcomes in RA patients using statins.
Main Results:
- Statins demonstrate mild anti-inflammatory benefits in rheumatoid arthritis.
- Part of statin's cardiovascular protective effect is independent of cholesterol reduction.
- Statins modulate leukocyte migration, T-cell activation, nitric oxide bioavailability, and angiogenesis.
Conclusions:
- Statins may provide dual benefits for rheumatoid arthritis patients: reducing cardiovascular risk and offering anti-inflammatory effects.
- Further research is warranted to fully elucidate the role of statins in managing RA and its associated comorbidities.